Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Gross Margin
Castle Biosciences Inc

81.9%
Current
80%
Average
47.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
81.9%
=
Gross Profit
255.4m
/
Revenue
311.9m

Gross Margin Across Competitors

Country US
Market Cap 873.7m USD
Gross Margin
82%
Country US
Market Cap 88.5B EUR
Gross Margin
11%
Country US
Market Cap 90.7B USD
Gross Margin
11%
Country US
Market Cap 68.1B USD
Gross Margin
14%
Country DE
Market Cap 24B EUR
Gross Margin
25%
Country US
Market Cap 20.1B USD
Gross Margin
28%
Country DE
Market Cap 18.6B EUR
Gross Margin
23%
Country US
Market Cap 17.6B USD
Gross Margin
33%
Country US
Market Cap 13B USD
Gross Margin
33%
Country DE
Market Cap 12B EUR
Gross Margin
25%
Country US
Market Cap 8.5B USD
Gross Margin
36%

Profitability Report

View the profitability report to see the full profitability analysis for Castle Biosciences Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
81.9%
=
Gross Profit
255.4m
/
Revenue
311.9m
What is the Gross Margin of Castle Biosciences Inc?

Based on Castle Biosciences Inc's most recent financial statements, the company has Gross Margin of 81.9%.